Germany’s Drug-Pricing Investigation: When Trade Pressure Creates More Uncertainty
USTR’s Section 301 investigation into German drug pricing could affect reimbursement, launch timing and investment while placing further strain on U.S.–German trade relations.
What Rutledge Still Means for PBM Regulation
What Rutledge and Mulready mean for PBM regulation, pharmacy reimbursement, 340B, network design, contracts and federal oversight.
The Legal Questions Behind a Pharmaceutical Manufacturing Move
A pharmaceutical manufacturing move involves real estate, FDA compliance, incentives, trade rules, contracts and long-term operational risk.